2 penny stocks with enormous potential

Edward Sheldon has been scanning the market for penny stocks with a lot of potential. And he believes these two are worth a look.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Penny stocks can have a place in a well-diversified portfolio. They’re higher risk, but the returns can be explosive.

Here, I’m going to highlight two top penny stocks on the London Stock Exchange. In my view, these shares have bags of potential.

In a strong position

First up is hVIVO (LSE: HVO).

It’s a small healthcare company that offers services for clinical trials and lab testing. Playing a vital role in the pharma industry, it serves several of the world’s largest global biopharmaceutical companies.

A recent trading update from hVIVO was very positive.

For starters, the company said that right now, it’s in its “strongest ever position” with 90% of 2024 revenue guidance already contracted, and record revenue visibility into 2025. For 2024, it expects to achieve revenue of £62m (+11% year on year)

Secondly, it advised that it’s on schedule to open a new state-of-the-art facility in Canary Wharf, London, in the first half of the 2024. This will enable the company to meet the growing demand for human challenge trials and allow it to further scale up. By 2028, it is hoping to be generating revenues of £100m per year.

I am excited about 2024 as we look forward to our move to a larger facility and the further diversification of our services.

Dr Yamin ‘Mo’ Khan, CEO of hVIVO

At present, hVIVO shares trade on a forward-looking price-to-earnings (P/E) ratio of around 23. This above-average valuation does add some risk.

Given the strong growth the company is generating right now, however, I think the overall risk/reward skew is attractive.

Taking a long-term view, I think the stock is likely to move higher.

Unlocking new opportunities

The other penny stock I want to highlight is Netcall (LSE: NET).

It’s a technology company that specialises in artificial intelligence-powered process automation and customer engagement software. Its customers include Legal & General, Nationwide, and the NHS.

This company has a great growth track record. Over the last five years, its revenue has grown from £21.9m to £36m (+64%) as organisations have embraced its automation solutions. And looking ahead, analysts expect the top-line growth to continue with a figure of £39.1m forecast for the year ending 30 June 2024 and £43.4m estimated for the following year.

It’s worth noting that management was quite bullish in a recent trading update. “We remain well positioned as we enter the second half, with our innovative product roadmap continuing to unlock new opportunities in a structurally-growing market,” said CEO James Ormondroyd.

Now, this stock has a higher valuation too. Currently, the forward-looking P/E ratio here is about 31.

I don’t think that’s unreasonable given that the technology company is growing rapidly and has a lot of recurring revenues.

But it does add some risk to the investment case. If growth slows, the stock could be volatile.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Edward Sheldon has positions in London Stock Exchange Group Plc. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Person holding magnifying glass over important document, reading the small print
Investing Articles

Just released: our top 3 small-cap stocks to consider buying in October [PREMIUM PICKS]

Small-cap shares tend to be more volatile than larger companies, so we suggest investors should look to build up a…

Read more »

Investing Articles

How I’d use an empty Stocks and Shares ISA to aim for a £1,000 monthly passive income

Here's how using a Stocks and Shares ISA really could help those of us who plan to invest for an…

Read more »

Investing Articles

This FTSE stock is up 20% and set for its best day ever! Time to buy?

This Fool takes a look at the half-year results from Burberry (LON:BRBY) to see if the struggling FTSE stock might…

Read more »

Investing Articles

This latest FTSE 100 dip could be an unmissable opportunity to pick up cut-price stocks

The FTSE 100 has pulled back with the government’s policy choices creating some negative sentiment. But this gives us a…

Read more »

A young woman sitting on a couch looking at a book in a quiet library space.
Investing Articles

As the WH Smith share price falls 4% on annual results, is it still worth considering?

WH Smith took a hit after this morning’s results left shareholders unimpressed. With the share price down 4%, Mark Hartley…

Read more »

Investing Articles

The Aviva share price just jumped 4.5% but still yields 7.02%! Time to buy?

A positive set of results has put fresh life into the Aviva share price. Harvey Jones says it offers bags…

Read more »

Investing Articles

Can a €500m buyback kickstart the Vodafone share price?

The Vodafone share price has been a loser for investors in recent years, and the dividend has been cut. We…

Read more »

Frustrated young white male looking disconsolate while sat on his sofa holding a beer
Growth Shares

3 mistakes I now avoid when choosing which growth stocks to buy

Jon Smith runs through some of the lessons he's learnt the hard way over the years about what to look…

Read more »